HNSCC tumors are characteristically very heterogenous, whether by location, etiology (HPV-related versus smoking-related), or biomarkers (PD-L1 expressing versus not) and we have learned that these patient and tumor traits can predict the varied biological responses to therapies. The gene discussed is CD274; the disease is neoplasm.